Related Experiment Videos

Role of inducible nitric oxide synthase in dextran sulphate sodium-induced colitis

Y Yoshida1, A Iwai, K Itoh

  • 1The Second Department of Internal Medicine, National Defense Medical College, School of Medicine, Tokorozawa, Saitama, Japan.

Abstract

Insights

Nitric oxide (NO) plays a dual role in acute colitis. Inhibiting NO worsened inflammation, but excessive NO donors also aggravated symptoms, indicating a need for balanced NO levels in ulcerative colitis treatment.

Area of Science:

  • Gastroenterology
  • Immunology
  • Pharmacology

Background:

  • Nitric oxide (NO) has been implicated in active inflammation, with conflicting reports on its toxic and protective roles.
  • The specific contribution of inducible nitric oxide synthase (iNOS)-derived NO in inflammatory conditions remains unclear.

Purpose of the Study:

  • To investigate the role of NO, particularly iNOS-derived NO, in experimental acute colitis.
  • To evaluate the effects of nitric oxide synthase (NOS) inhibitors and NO donors on inflammation.

Main Methods:

  • Acute colitis was induced in rats using dextran sulphate sodium (DSS).
  • Inflammatory markers assessed included white blood cell counts, thiobarbituric acid reactants in portal blood, and colonic mucosal histology.
  • The effects of N(G)-nitro-L-arginine methyl ester (L-NAME), aminoguanidine (AG), and an NO donor were examined.

Main Results:

  • Inhibition of NO production using L-NAME or AG exacerbated DSS-induced colitis.
  • Administration of an NO donor also worsened inflammatory parameters in DSS-induced colitis.

Conclusions:

  • NO appears to have a protective role in acute colitis, as its inhibition worsened the condition.
  • Both insufficient and excessive NO levels can aggravate acute colitis, suggesting a critical balance is required.
  • Therapeutic strategies for ulcerative colitis should focus on maintaining optimal NO levels within the intestinal mucosa.

Related Concept Videos